{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:07:10Z","timestamp":1768014430801,"version":"3.49.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-025-02343-3","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:38:04Z","timestamp":1767613084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Management of Coronary Stent Thrombosis: A Contemporary Guide"],"prefix":"10.1007","volume":"28","author":[{"given":"Tanawat","family":"Attachaipanich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Affan","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafeez Ul Hassan","family":"Virk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzamil","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Jneid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"4","key":"2343_CR1","volume":"2","author":"LW Klein","year":"2023","unstructured":"Klein LW, Nathan S, Maehara A, Messenger J, Mintz GS, Ali ZA, et al. SCAI expert consensus statement on management of in-stent restenosis and stent thrombosis. J Soc Cardiovasc Angiogr Interv. 2023;2(4):100971.","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"15","key":"2343_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","volume":"71","author":"J Torrado","year":"2018","unstructured":"Torrado J, Buckley L, Dur\u00e1n A, Trujillo P, Toldo S, Valle Raleigh J, et al. Restenosis, stent Thrombosis, and bleeding complications: navigating between scylla and Charybdis. J Am Coll Cardiol. 2018;71(15):1676\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2343_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJM199408253310802","volume":"331","author":"DL Fischman","year":"1994","unstructured":"Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent restenosis study investigators. N Engl J Med. 1994;331(8):496\u2013501.","journal-title":"N Engl J Med"},{"issue":"6","key":"2343_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jacc.2016.11.055","volume":"69","author":"AM Gall\u00f8e","year":"2017","unstructured":"Gall\u00f8e AM, Kelb\u00e6k H, Thuesen L, Hansen HS, Ravkilde J, Hansen PR, et al. 10-year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents. J Am Coll Cardiol. 2017;69(6):616\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2343_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacc.2007.04.031","volume":"50","author":"R Jaffe","year":"2007","unstructured":"Jaffe R, Strauss BH. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol. 2007;50(2):119\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2343_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","volume":"75","author":"MV Madhavan","year":"2020","unstructured":"Madhavan MV, Kirtane AJ, Redfors B, G\u00e9n\u00e9reux P, Ben-Yehuda O, Palmerini T, et al. Stent-Related adverse Events\u2009>\u20091 year after percutaneous coronary intervention. J Am Coll Cardiol. 2020;75(6):590\u2013604.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2343_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018972","volume":"10","author":"S Enomoto","year":"2021","unstructured":"Enomoto S, Kuramitsu S, Shinozaki T, Ohya M, Otake H, Yamanaka F, et al. Risk factors and outcomes of recurrent drug-eluting stent thrombosis: insights from the REAL-ST Registry. J Am Heart Assoc. 2021;10(9):e018972.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2343_CR8","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","volume":"119","author":"JW van Werkum","year":"2009","unstructured":"van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation. 2009;119(6):828\u201334.","journal-title":"Circulation"},{"issue":"3","key":"2343_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jjcc.2019.02.019","volume":"74","author":"MC Kim","year":"2019","unstructured":"Kim MC, Kim IS, Jeong MH, Sim DS, Hong YJ, Kim JH, et al. Incidence of cardiac death and recurrent stent thrombosis after treatment for angiographically confirmed stent thrombosis. J Cardiol. 2019;74(3):267\u201372.","journal-title":"J Cardiol"},{"issue":"17","key":"2343_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126\u201330.","journal-title":"JAMA"},{"issue":"9562","key":"2343_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667\u201378.","journal-title":"Lancet"},{"issue":"17","key":"2343_CR12","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351.","journal-title":"Circulation"},{"issue":"2","key":"2343_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","volume":"167","author":"F D'Ascenzo","year":"2013","unstructured":"D\u2019Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2013;167(2):575\u201384.","journal-title":"Int J Cardiol"},{"issue":"16","key":"2343_CR14","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW van Werkum","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry. J Am Coll Cardiol. 2009;53(16):1399\u2013409.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2343_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/EIJV9I1A10","volume":"9","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, et al. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 2013;9(1):62\u20139.","journal-title":"EuroIntervention"},{"issue":"16","key":"2343_CR16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.110.981688","volume":"123","author":"GD Dangas","year":"2011","unstructured":"Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011;123(16):1745\u201356.","journal-title":"Circulation"},{"issue":"11","key":"2343_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jcin.2012.07.012","volume":"5","author":"GD Dangas","year":"2012","unstructured":"Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012;5(11):1097\u2013105.","journal-title":"JACC Cardiovasc Interv"},{"issue":"16","key":"2343_CR18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","volume":"306","author":"G Cayla","year":"2011","unstructured":"Cayla G, Hulot JS, O\u2019Connor SA, Pathak A, Scott SA, Gruel Y, et al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA. 2011;306(16):1765\u201374.","journal-title":"JAMA"},{"issue":"1","key":"2343_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/01.CIR.0000078636.71728.40","volume":"108","author":"E Cheneau","year":"2003","unstructured":"Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108(1):43\u20137.","journal-title":"Circulation"},{"issue":"9621","key":"2343_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","volume":"371","author":"SD Wiviott","year":"2008","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet. 2008;371(9621):1353\u201363.","journal-title":"Lancet"},{"issue":"16","key":"2343_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/jama.2010.1543","volume":"304","author":"JL Mega","year":"2010","unstructured":"Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010;304(16):1821\u201330.","journal-title":"JAMA"},{"issue":"8","key":"2343_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.111.032912","volume":"125","author":"SG Goodman","year":"2012","unstructured":"Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012;125(8):978\u201386.","journal-title":"Circulation"},{"issue":"9694","key":"2343_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","volume":"374","author":"ML O'Donoghue","year":"2009","unstructured":"O\u2019Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009;374(9694):989\u201397.","journal-title":"Lancet"},{"issue":"10","key":"2343_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jcin.2014.04.017","volume":"7","author":"R Waksman","year":"2014","unstructured":"Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, R\u00e4ber L, et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). JACC Cardiovasc Interv. 2014;7(10):1093\u2013102.","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"2343_CR25","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115(18):2435\u201341.","journal-title":"Circulation"},{"issue":"1","key":"2343_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","volume":"5","author":"G Guagliumi","year":"2012","unstructured":"Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv. 2012;5(1):12\u201320.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"2343_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357.","journal-title":"N Engl J Med"},{"issue":"7","key":"2343_CR28","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1253\/circj.CJ-10-1160","volume":"75","author":"KW Park","year":"2011","unstructured":"Park KW, Hwang SJ, Kwon DA, Oh BH, Park YB, Chae IH, et al. Characteristics and predictors of drug-eluting stent thrombosis: results from the multicenter \u2018Korea stent thrombosis (KoST)\u2019 registry. Circ J. 2011;75(7):1626\u201332.","journal-title":"Circ J"},{"issue":"5","key":"2343_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.amjcard.2008.04.068","volume":"102","author":"KW Baran","year":"2008","unstructured":"Baran KW, Lasala JM, Cox DA, Song A, Deshpande MC, Jacoski MV, Mascioli SR. A clinical risk score for prediction of stent thrombosis. Am J Cardiol. 2008;102(5):541\u20135.","journal-title":"Am J Cardiol"},{"issue":"21","key":"2343_CR30","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","volume":"358","author":"GW Stone","year":"2008","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358(21):2218\u201330.","journal-title":"N Engl J Med"},{"issue":"21","key":"2343_CR31","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa062437","volume":"355","author":"GW Stone","year":"2006","unstructured":"Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355(21):2203\u201316.","journal-title":"N Engl J Med"},{"key":"2343_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15040151","author":"J Fluder-Wlodarczyk","year":"2025","unstructured":"Fluder-Wlodarczyk J, Darakhovich M, Schneider Z, Roleder-Dylewska M, Dobroli\u0144ska M, Paw\u0142owski T, et al. Artificial intelligence-based algorithm for stent coverage assessments. J Pers Med. 2025. https:\/\/doi.org\/10.3390\/jpm15040151.","journal-title":"J Pers Med"},{"key":"2343_CR33","doi-asserted-by":"crossref","unstructured":"yu m, Tan F. jiang y. Abstract 4142793: Development of an Angiography-Based Multimodal AI Model for Predicting the risk of In-Stent Restenosis. Circulation. 2024;150(Suppl_1):A4142793-A.","DOI":"10.1161\/circ.150.suppl_1.4142793"},{"issue":"10","key":"2343_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","volume":"7","author":"BE Claessen","year":"2014","unstructured":"Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD. Stent thrombosis: a clinical perspective. JACC Cardiovasc Interv. 2014;7(10):1081\u201392.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"2343_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","volume":"136","author":"T Adriaenssens","year":"2017","unstructured":"Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (Prevention of late stent thrombosis by an interdisciplinary global European Effort). Circulation. 2017;136(11):1007\u201321.","journal-title":"Circulation"},{"issue":"15","key":"2343_CR36","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","volume":"37","author":"G Souteyrand","year":"2016","unstructured":"Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the National PESTO French registry. Eur Heart J. 2016;37(15):1208\u201316.","journal-title":"Eur Heart J"},{"issue":"22","key":"2343_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026492","volume":"11","author":"E Erdogan","year":"2022","unstructured":"Erdogan E, Bajaj R, Lansky A, Mathur A, Baumbach A, Bourantas CV. Intravascular imaging for guiding In-Stent Restenosis and Stent Thrombosis Therapy. J Am Heart Assoc. 2022;11(22):e026492.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2343_CR38","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jcin.2015.06.015","volume":"8","author":"AP Antoniadis","year":"2015","unstructured":"Antoniadis AP, Mortier P, Kassab G, Dubini G, Foin N, Murasato Y, et al. Biomechanical modeling to improve coronary artery bifurcation stenting: expert review document on techniques and clinical implementation. JACC Cardiovasc Interv. 2015;8(10):1281\u201396.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2343_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129(2):211\u201323.","journal-title":"Circulation"},{"issue":"7","key":"2343_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","volume":"133","author":"M Taniwaki","year":"2016","unstructured":"Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, et al. Mechanisms of very late Drug-Eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016;133(7):650\u201360.","journal-title":"Circulation"},{"issue":"11","key":"2343_CR41","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/hrt.2007.132555","volume":"93","author":"M Takano","year":"2007","unstructured":"Takano M, Yamamoto M, Xie Y, Murakami D, Inami S, Okamatsu K, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart. 2007;93(11):1353\u20136.","journal-title":"Heart"},{"issue":"1","key":"2343_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","volume":"7","author":"E Im","year":"2014","unstructured":"Im E, Kim BK, Ko YG, Shin DH, Kim JS, Choi D, et al. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv. 2014;7(1):88\u201396.","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2343_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCULATIONAHA.105.563403","volume":"113","author":"MK Hong","year":"2006","unstructured":"Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113(3):414\u20139.","journal-title":"Circulation"},{"issue":"18","key":"2343_CR44","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426\u201334.","journal-title":"Circulation"},{"issue":"2","key":"2343_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.113.000931","volume":"7","author":"N Foin","year":"2014","unstructured":"Foin N, Guti\u00e9rrez-Chico JL, Nakatani S, Torii R, Bourantas CV, Sen S, et al. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. Circ Cardiovasc Interv. 2014;7(2):180\u20139.","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"2343_CR46","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/ATVBAHA.117.309728","volume":"37","author":"J Ng","year":"2017","unstructured":"Ng J, Bourantas CV, Torii R, Ang HY, Tenekecioglu E, Serruys PW, Foin N. Local hemodynamic forces after stenting: implications on restenosis and thrombosis. Arterioscler Thromb Vasc Biol. 2017;37(12):2231\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"32","key":"2343_CR47","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36(32):2147\u201359.","journal-title":"Eur Heart J"},{"issue":"11","key":"2343_CR48","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57(11):1314\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2343_CR49","doi-asserted-by":"publisher","first-page":"e001878","DOI":"10.1161\/CIRCINTERVENTIONS.114.001878","volume":"8","author":"SY Lee","year":"2015","unstructured":"Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv. 2015;8(2):e001878.","journal-title":"Circ Cardiovasc Interv"},{"issue":"23","key":"2343_CR50","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.jcin.2017.06.059","volume":"10","author":"H Mori","year":"2017","unstructured":"Mori H, Cheng Q, Lutter C, Smith S, Guo L, Kutyna M, et al. Endothelial barrier protein expression in biodegradable polymer Sirolimus-Eluting versus durable polymer Everolimus-Eluting metallic stents. JACC Cardiovasc Interv. 2017;10(23):2375\u201387.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"2343_CR51","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jcin.2016.02.025","volume":"9","author":"J Kan","year":"2016","unstructured":"Kan J, Ge Z, Zhang JJ, Liu ZZ, Tian NL, Ye F, et al. Incidence and clinical outcomes of stent fractures on the basis of 6,555 patients and 16,482 drug-eluting stents from 4 centers. JACC Cardiovasc Interv. 2016;9(11):1115\u201323.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"2343_CR52","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jcin.2014.06.016","volume":"7","author":"Y Onuma","year":"2014","unstructured":"Onuma Y, Serruys PW, Muramatsu T, Nakatani S, van Geuns RJ, de Bruyne B, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B trial (A clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de Novo native coronary artery Lesions). JACC Cardiovasc Interv. 2014;7(12):1400\u201311.","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"2343_CR53","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","volume":"140","author":"DJ Kereiakes","year":"2019","unstructured":"Kereiakes DJ, Ellis SG, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, et al. Clinical outcomes before and after complete Everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial. Circulation. 2019;140(23):1895\u2013903.","journal-title":"Circulation"},{"issue":"3","key":"2343_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","volume":"82","author":"GW Stone","year":"2023","unstructured":"Stone GW, Kereiakes DJ, Gori T, Metzger DC, Stein B, Erickson M, et al. 5-year outcomes after bioresorbable coronary scaffolds implanted with improved technique. J Am Coll Cardiol. 2023;82(3):183\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2343_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jacc.2023.05.023","volume":"82","author":"PW Serruys","year":"2023","unstructured":"Serruys PW, Revaiah PC, Onuma Y. Bioresorbable scaffolds: is there still light at the end of the tunnel? J Am Coll Cardiol. 2023;82(3):196\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2343_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002107","author":"E Jackson-Smith","year":"2022","unstructured":"Jackson-Smith E, Zioupos S, Banerjee P. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials. Open Heart. 2022. https:\/\/doi.org\/10.1136\/openhrt-2022-002107.","journal-title":"Open Heart"},{"issue":"6","key":"2343_CR57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701\u20135.","journal-title":"Circulation"},{"issue":"9807","key":"2343_CR58","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","volume":"378","author":"GG Stefanini","year":"2011","unstructured":"Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet. 2011;378(9807):1940\u20138.","journal-title":"Lancet"},{"issue":"6","key":"2343_CR59","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacc.2024.10.074","volume":"85","author":"RW Yeh","year":"2025","unstructured":"Yeh RW, Bertrand OF, Mahmud E, Barbato E, Falah B, Issever MO, et al. Randomized comparison of novel Low-Dose Sirolimus-Eluting biodegradable polymer stent vs Second-Generation DES: TARGET-IV NA trial. J Am Coll Cardiol. 2025;85(6):563\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2343_CR60","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.120.051700","volume":"143","author":"HS Kim","year":"2021","unstructured":"Kim HS, Kang J, Hwang D, Han JK, Yang HM, Kang HJ, et al. Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST-REDUCE-POLYTECH-ACS trial. Circulation. 2021;143(11):1081\u201391.","journal-title":"Circulation"},{"issue":"1","key":"2343_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jcin.2019.08.020","volume":"13","author":"JC Choe","year":"2020","unstructured":"Choe JC, Cha KS, Lee JG, Kim J, Shin JY, Ahn J, et al. Long-term outcomes of biodegradable versus second-generation durable polymer drug-eluting stent implantations for myocardial infarction. JACC Cardiovasc Interv. 2020;13(1):97\u2013111.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"2343_CR62","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jcin.2017.02.029","volume":"10","author":"GJ Vlachojannis","year":"2017","unstructured":"Vlachojannis GJ, Smits PC, Hofma SH, Togni M, V\u00e1zquez N, Vald\u00e9s M, et al. Biodegradable polymer Biolimus-Eluting stents versus durable polymer Everolimus-Eluting stents in patients with coronary artery disease: final 5-Year report from the COMPARE II trial (Abluminal biodegradable polymer Biolimus-Eluting stent versus durable polymer Everolimus-Eluting stent). JACC Cardiovasc Interv. 2017;10(12):1215\u201321.","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2343_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jcin.2016.11.007","volume":"10","author":"B Raungaard","year":"2017","unstructured":"Raungaard B, Christiansen EH, B\u00f8tker HE, Hansen HS, Ravkilde J, Thuesen L, et al. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting coronary stents in patients with coronary artery disease: 3-Year clinical outcomes in the randomized SORT OUT VI trial. JACC Cardiovasc Interv. 2017;10(3):255\u201364.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2343_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jcin.2020.12.011","volume":"14","author":"T Pilgrim","year":"2021","unstructured":"Pilgrim T, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, et al. Biodegradable- versus Durable-Polymer Drug-Eluting stents for STEMI: final 2-Year outcomes of the BIOSTEMI trial. JACC Cardiovasc Interv. 2021;14(6):639\u201348.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"2343_CR65","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jcin.2014.05.017","volume":"7","author":"EJ Armstrong","year":"2014","unstructured":"Armstrong EJ, Sab S, Singh GD, Lim W, Yeo KK, Waldo SW, et al. Predictors and outcomes of recurrent stent thrombosis. JACC Cardiovasc Interv. 2014;7(10):1105\u201313.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"2343_CR66","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e364-467.","journal-title":"Stroke"},{"issue":"5","key":"2343_CR67","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1227\/NEU.0b013e318286fdc8","volume":"72","author":"CP Derdeyn","year":"2013","unstructured":"Derdeyn CP, Fiorella D, Lynn MJ, Rumboldt Z, Cloft HJ, Gibson D, et al. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013;72(5):777\u201395. discussion 95.","journal-title":"Neurosurgery"},{"issue":"3","key":"2343_CR68","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/STROKEAHA.116.015538","volume":"48","author":"X Sun","year":"2017","unstructured":"Sun X, Tong X, Lo WT, Mo D, Gao F, Ma N, et al. Risk factors of subacute thrombosis after intracranial stenting for symptomatic intracranial arterial stenosis. Stroke. 2017;48(3):784\u20136.","journal-title":"Stroke"},{"issue":"4","key":"2343_CR69","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/STROKEAHA.108.531400","volume":"40","author":"CH Riedel","year":"2009","unstructured":"Riedel CH, Tietke M, Alfke K, Stingele R, Jansen O. Subacute stent thrombosis in intracranial stenting. Stroke. 2009;40(4):1310\u20134.","journal-title":"Stroke"},{"key":"2343_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jocn.2020.09.020","volume":"81","author":"G Saal-Zapata","year":"2020","unstructured":"Saal-Zapata G, Durand W, Ghodke BV, Walker M. Endovascular strategies for stroke management after subacute in-stent thrombosis. J Clin Neurosci. 2020;81:18\u201320.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"2343_CR71","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993\u20131003.","journal-title":"N Engl J Med"},{"issue":"7","key":"2343_CR72","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/1538574416665986","volume":"50","author":"KG Moulakakis","year":"2016","unstructured":"Moulakakis KG, Mylonas SN, Lazaris A, Tsivgoulis G, Kakisis J, Sfyroeras GS, et al. Acute carotid stent thrombosis: A comprehensive review. Vasc Endovascular Surg. 2016;50(7):511\u201321.","journal-title":"Vasc Endovascular Surg"},{"issue":"3","key":"2343_CR73","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jvs.2018.09.053","volume":"69","author":"AP Coelho","year":"2019","unstructured":"Coelho AP, Lobo M, Nogueira C, Gouveia R, Campos J, Augusto R, et al. Overview of evidence on risk factors and early management of acute carotid stent thrombosis during the last two decades. J Vasc Surg. 2019;69(3):952\u201364.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2343_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.carrev.2009.02.008","volume":"11","author":"A Iancu","year":"2010","unstructured":"Iancu A, Grosz C, Lazar A. Acute carotid stent thrombosis: review of the literature and long-term follow-up. Cardiovasc Revasc Med. 2010;11(2):110\u20133.","journal-title":"Cardiovasc Revasc Med"},{"issue":"11","key":"2343_CR75","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/jnis-2022-019844","volume":"15","author":"CM Schirmer","year":"2023","unstructured":"Schirmer CM, Bulsara KR, Al-Mufti F, Haranhalli N, Thibault L, Hetts SW. Antiplatelets and antithrombotics in neurointerventional procedures: guideline update. J Neurointerv Surg. 2023;15(11):1155\u201362.","journal-title":"J Neurointerv Surg"},{"issue":"3","key":"2343_CR76","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/STROKEAHA.124.048743","volume":"56","author":"J Yoo","year":"2025","unstructured":"Yoo J, Lim H, Seo KD. Optimal duration of dual antiplatelet therapy after carotid artery stenting: a nationwide cohort study. Stroke. 2025;56(3):613\u201320.","journal-title":"Stroke"},{"issue":"5","key":"2343_CR77","volume":"4","author":"K Fukutome","year":"2024","unstructured":"Fukutome K, Aketa S, Fukumori J, Mitsui T, Shiraishi Y, Hayami H, et al. Optimal dual antiplatelet therapy duration for carotid artery stenting on the basis of angioscopic findings. Stroke Vasc Interv Neurol. 2024;4(5):e001350.","journal-title":"Stroke Vasc Interv Neurol"},{"issue":"2","key":"2343_CR78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002730","volume":"9","author":"S Banerjee","year":"2016","unstructured":"Banerjee S, Sarode K, Mohammad A, Gigliotti O, Baig MS, Tsai S, et al. Femoropopliteal artery stent thrombosis: report from the Excellence in Peripheral Artery Disease Registry. Circ Cardiovasc Interv. 2016;9(2):e002730.","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"2343_CR79","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00270-016-1513-0","volume":"40","author":"K Katsanos","year":"2017","unstructured":"Katsanos K, Al-Lamki SA, Parthipun A, Spiliopoulos S, Patel SD, Paraskevopoulos I, et al. Peripheral stent thrombosis leading to acute limb ischemia and major amputation: incidence and risk factors in the aortoiliac and femoropopliteal arteries. Cardiovasc Intervent Radiol. 2017;40(3):351\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"12","key":"2343_CR80","doi-asserted-by":"publisher","first-page":"e1107","DOI":"10.4244\/EIJ-D-19-00187","volume":"15","author":"C Bradaric","year":"2019","unstructured":"Bradaric C, Koppara T, M\u00fcller A, Haller B, Ott I, Cassese S, et al. Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery. EuroIntervention. 2019;15(12):e1107\u201314.","journal-title":"EuroIntervention"},{"issue":"4","key":"2343_CR81","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jcin.2019.10.060","volume":"13","author":"SH Kuntz","year":"2020","unstructured":"Kuntz SH, Torii S, Jinnouchi H, Cornelissen A, Sakamoto A, Sato Y, et al. Pathology and multimodality imaging of acute and chronic femoral stenting in humans. JACC Cardiovasc Interv. 2020;13(4):418\u201327.","journal-title":"JACC Cardiovasc Interv"},{"key":"2343_CR82","doi-asserted-by":"crossref","unstructured":"Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2024;149(24):e1313-410.","DOI":"10.1161\/CIR.0000000000001251"},{"issue":"23","key":"2343_CR83","first-page":"2359","volume":"12","author":"S Cho","year":"2019","unstructured":"Cho S, Lee YJ, Ko YG, Kang TS, Lim SH, Hong SJ, et al. Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease. JACC: Cardiovascular Interventions. 2019;12(23):2359\u201370.","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"1","key":"2343_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1540-8191.2007.00332.x","volume":"22","author":"JH Rogers","year":"2007","unstructured":"Rogers JH, Calhoun RF 2. Diagnosis and management of subclavian artery stenosis prior to coronary artery bypass grafting in the current era. J Card Surg. 2007;22(1):20\u20135.","journal-title":"J Card Surg"},{"issue":"2","key":"2343_CR85","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12928-013-0199-3","volume":"29","author":"R Silingardi","year":"2014","unstructured":"Silingardi R, Lauricella A, Cataldi V, Njila MK, Coppi G. Mechanical thrombectomy in proximal subclavian artery in-stent occlusion. Cardiovasc Interv Ther. 2014;29(2):140\u20135.","journal-title":"Cardiovasc Interv Ther"},{"issue":"39","key":"2343_CR86","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","volume":"42","author":"V Aboyans","year":"2021","unstructured":"Aboyans V, Bauersachs R, Mazzolai L, Brodmann M, Palomares JFR, Debus S, et al. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart J. 2021;42(39):4013\u201324.","journal-title":"Eur Heart J"},{"issue":"13","key":"2343_CR87","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","volume":"127","author":"JL Anderson","year":"2013","unstructured":"Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American college of cardiology Foundation\/American heart association task force on practice guidelines. Circulation. 2013;127(13):1425\u201343.","journal-title":"Circulation"},{"issue":"1","key":"2343_CR88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiology.216.1.r00jl0778","volume":"216","author":"TC Leertouwer","year":"2000","unstructured":"Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216(1):78\u201385.","journal-title":"Radiology"},{"issue":"1","key":"2343_CR89","first-page":"28","volume":"6","author":"P Jariwala","year":"2022","unstructured":"Jariwala P, Jadhav K, Madhawar DB, Shaikh S. Stent thrombosis of the drug-eluting stent after percutaneous transluminal renal angioplasty of single functioning kidney in-patient with takayasu\u2019s arteritis-induced bilateral renal artery stenosis. IHJ Cardiovasc Case Rep (CVCR). 2022;6(1):28\u201332.","journal-title":"IHJ Cardiovasc Case Rep (CVCR)"},{"issue":"7","key":"2343_CR90","doi-asserted-by":"publisher","first-page":"e9545","DOI":"10.1016\/j.avsg.2010.03.017","volume":"24","author":"M Boufi","year":"2010","unstructured":"Boufi M, Orsini B, Bianca D, Hartung O, Brunet P, Alimi YS. Renal artery thrombosis caused by stent fracture: the risk of undiagnosed renal artery entrapment. Ann Vasc Surg. 2010;24(7):e9545\u20138.","journal-title":"Ann Vasc Surg"},{"issue":"5","key":"2343_CR91","first-page":"747","volume":"38","author":"S Passey","year":"2025","unstructured":"Passey S, Pandey S, Mehta A, Meng J, Azrin M. Renal artery stent thrombosis as a complication of percutaneous renal artery revascularization and stent placement. Proc (Bayl Univ Med Cent). 2025;38(5):747\u201350.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"2343_CR92","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jvs.2011.10.122","volume":"55","author":"GS Oderich","year":"2012","unstructured":"Oderich GS, Tallarita T, Gloviczki P, Duncan AA, Kalra M, Misra S, et al. Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia. J Vasc Surg. 2012;55(4):1063\u201371.","journal-title":"J Vasc Surg"},{"issue":"6","key":"2343_CR93","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/1538574407306242","volume":"41","author":"D Sutphin","year":"2007","unstructured":"Sutphin D, Stevens S, Kirzeder D, Gash J. Acute thrombosis of a mesenteric artery drug-eluting stent following clopidogrel cessation. Vasc Endovascular Surg. 2007;41(6):564\u20137.","journal-title":"Vasc Endovascular Surg"},{"issue":"6","key":"2343_CR94","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.hlc.2014.11.028","volume":"24","author":"O Ait-Mokhtar","year":"2015","unstructured":"Ait-Mokhtar O, Bayet G, Benamara S, Brunet J, Hager FX, Sainsous J. Very late mesenteric bare metal stent thrombosis in the setting of cessation of antiplatelet agents. Heart Lung Circ. 2015;24(6):e65\u20137.","journal-title":"Heart Lung Circ"},{"issue":"35","key":"2343_CR95","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","volume":"39","author":"L R\u00e4ber","year":"2018","unstructured":"R\u00e4ber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39(35):3281\u2013300.","journal-title":"Eur Heart J"},{"issue":"10060","key":"2343_CR96","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","volume":"388","author":"ZA Ali","year":"2016","unstructured":"Ali ZA, Maehara A, G\u00e9n\u00e9reux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016;388(10060):2618\u201328.","journal-title":"Lancet"},{"issue":"14","key":"2343_CR97","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/CIRCULATIONAHA.123.067583","volume":"149","author":"D Giacoppo","year":"2024","unstructured":"Giacoppo D, Laudani C, Occhipinti G, Spagnolo M, Greco A, Rochira C, et al. Coronary angiography, intravascular ultrasound, and optical coherence tomography for guiding of percutaneous coronary intervention: a systematic review and network meta-analysis. Circulation. 2024;149(14):1065\u201386.","journal-title":"Circulation"},{"issue":"3","key":"2343_CR98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcin.2020.10.001","volume":"14","author":"XF Gao","year":"2021","unstructured":"Gao XF, Ge Z, Kong XQ, Kan J, Han L, Lu S, et al. 3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation. JACC Cardiovasc Interv. 2021;14(3):247\u201357.","journal-title":"JACC Cardiovasc Interv"},{"issue":"38","key":"2343_CR99","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"13","key":"2343_CR100","first-page":"e771","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2025;151(13):e771-862.","journal-title":"Circulation"},{"issue":"9","key":"2343_CR101","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.4244\/EIJV8I9A159","volume":"8","author":"GD Dangas","year":"2013","unstructured":"Dangas GD, Claessen BE, Mehran R, Xu K, Stone GW. Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. EuroIntervention. 2013;8(9):1033\u20139.","journal-title":"EuroIntervention"},{"key":"2343_CR102","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001362","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Rutledge DR, Palmerini T, Caixeta A, Kedhi E, Hermiller JB, et al. Stent thrombosis and dual antiplatelet therapy interruption with everolimus-eluting stents: insights from the Xience V coronary stent system trials. Circ Cardiovasc Interv. 2015. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.001362.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9906","key":"2343_CR103","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","volume":"382","author":"R Mehran","year":"2013","unstructured":"Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013;382(9906):1714\u201322.","journal-title":"Lancet"},{"issue":"13","key":"2343_CR104","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","volume":"65","author":"G Giustino","year":"2015","unstructured":"Giustino G, Baber U, Sartori S, Mehran R, Mastoris I, Kini AS, et al. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2015;65(13):1298\u2013310.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2343_CR105","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","volume":"46","author":"PA Gurbel","year":"2005","unstructured":"Gurbel PA, Bliden KP, Samara W, Yoho JA, Hayes K, Fissha MZ, Tantry US. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST study. J Am Coll Cardiol. 2005;46(10):1827\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2343_CR106","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","volume":"29","author":"MJ Price","year":"2008","unstructured":"Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008;29(8):992\u20131000.","journal-title":"Eur Heart J"},{"issue":"1","key":"2343_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40261-018-0711-8","volume":"39","author":"S Zhao","year":"2019","unstructured":"Zhao S, Zhong Z, Qi G, Shi L, Tian W. Effects of cilostazol-based triple antiplatelet therapy versus dual antiplatelet therapy after coronary drug-eluting stent implantation: an updated meta-analysis of the randomized controlled trials. Clin Drug Investig. 2019;39(1):1\u201313.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"2343_CR108","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jcin.2013.04.022","volume":"6","author":"KW Park","year":"2013","unstructured":"Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, et al. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing optimal strategy for treatment of coronary artery Stenosis-Safety & effectiveness of Drug-Eluting stents & Anti-platelet Regimen). JACC Cardiovasc Interv. 2013;6(9):932\u201342.","journal-title":"JACC Cardiovasc Interv"},{"issue":"Fi1","key":"2343_CR109","first-page":"f50","volume":"7","author":"G Gargiulo","year":"2021","unstructured":"Gargiulo G, Cannon CP, Gibson CM, Goette A, Lopes RD, Oldgren J, et al. Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J. 2021;7(Fi1):f50\u201360.","journal-title":"Eur Heart J"},{"issue":"9","key":"2343_CR110","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","volume":"141","author":"RD Lopes","year":"2020","unstructured":"Lopes RD, Leonardi S, Wojdyla DM, Vora AN, Thomas L, Storey RF, et al. Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial. Circulation. 2020;141(9):781\u20133.","journal-title":"Circulation"},{"issue":"1","key":"2343_CR111","doi-asserted-by":"publisher","first-page":"100172","DOI":"10.1016\/j.jacadv.2022.100172","volume":"2","author":"S Shoji","year":"2023","unstructured":"Shoji S, Sawano M, Inohara T, Hiraide T, Ueda I, Suzuki M, et al. Genetic backgrounds associated with stent thrombosis: A pilot study from a percutaneous coronary intervention registry. JACC Adv. 2023;2(1):100172.","journal-title":"JACC Adv"},{"issue":"24","key":"2343_CR112","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","volume":"363","author":"C Kaiser","year":"2010","unstructured":"Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, et al. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med. 2010;363(24):2310\u20139.","journal-title":"N Engl J Med"},{"issue":"9784","key":"2343_CR113","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","volume":"377","author":"GW Stone","year":"2011","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al. Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011;377(9784):2193\u2013204.","journal-title":"Lancet"},{"issue":"10016","key":"2343_CR114","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","volume":"387","author":"M Sabat\u00e9","year":"2016","unstructured":"Sabat\u00e9 M, Brugaletta S, Cequier A, I\u00f1iguez A, Serra A, Jim\u00e9nez-Quevedo P, et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet. 2016;387(10016):357\u201366.","journal-title":"Lancet"},{"issue":"13","key":"2343_CR115","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","volume":"375","author":"KH B\u00f8naa","year":"2016","unstructured":"B\u00f8naa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nyg\u00e5rd O, et al. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375(13):1242\u201352.","journal-title":"N Engl J Med"},{"issue":"18","key":"2343_CR116","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","volume":"362","author":"GW Stone","year":"2010","unstructured":"Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;362(18):1663\u201374.","journal-title":"N Engl J Med"},{"issue":"9","key":"2343_CR117","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"PC Smits","year":"2015","unstructured":"Smits PC, Vlachojannis GJ, McFadden EP, Royaards KJ, Wassing J, Joesoef KS, et al. Final 5-Year Follow-Up of a randomized controlled trial of Everolimus- and Paclitaxel-Eluting stents for coronary revascularization in daily practice: the COMPARE trial (A trial of Everolimus-Eluting stents and Paclitaxel stents for coronary revascularization in daily Practice). JACC Cardiovasc Interv. 2015;8(9):1157\u201365.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"2343_CR118","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","volume":"125","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR, et al. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian organization for randomized trials with clinical outcome IV (SORT OUT IV). Circulation. 2012;125(10):1246\u201355.","journal-title":"Circulation"},{"issue":"7","key":"2343_CR119","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jcin.2019.01.234","volume":"12","author":"H Shiomi","year":"2019","unstructured":"Shiomi H, Kozuma K, Morimoto T, Kadota K, Tanabe K, Morino Y, et al. 7-Year outcomes of a randomized trial comparing the First-Generation Sirolimus-Eluting stent versus the New-Generation Everolimus-Eluting stent: the RESET trial. JACC Cardiovasc Interv. 2019;12(7):637\u201347.","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"2343_CR120","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.jcin.2022.07.027","volume":"15","author":"DE Kandzari","year":"2022","unstructured":"Kandzari DE, Koolen JJ, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, et al. Ultrathin bioresorbable polymer Sirolimus-Eluting stents versus durable polymer Everolimus-Eluting stents: BIOFLOW V final 5-Year outcomes. JACC Cardiovasc Interv. 2022;15(18):1852\u201360.","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"2343_CR121","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","volume":"376","author":"JJ Wykrzykowska","year":"2017","unstructured":"Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, AJ IJ, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med. 2017;376(24):2319\u201328.","journal-title":"N Engl J Med"},{"issue":"16","key":"2343_CR122","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","volume":"17","author":"LSM Kerkmeijer","year":"2022","unstructured":"Kerkmeijer LSM, Renkens MPL, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout EK, et al. Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial. EuroIntervention. 2022;17(16):1340\u20137.","journal-title":"EuroIntervention"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-025-02343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:03:50Z","timestamp":1767989030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-025-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s11886-025-02343-3","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"9"}}